Skip to main content
Book cover

90. Kongreß pp 1445–1479Cite as

Postersession III

Diabetes

  • Conference paper
  • 28 Accesses

Part of the book series: Verhandlungen der Deutschen Gesellschaft für Innere Medizin ((VDGINNERE,volume 90))

Zusammenfassung

Diabetes mellitus (DM) ist ein klinisches Syndrom, dessen Häufigkeit in den westlichen Industriestaaten auf 1,5–2,5% geschätzt wird [1] und dessen Prävalenz genetisch bedingt in manchen Populationen (Pima-Indianer) allein für den Typ 2 bis zu 35% betragen kann [2]. Im allgemeinen wird jedoch der relative Anteil der nichtinsulinabhängigen (Typ 2) Diabetiker an der Gesamtprävalenz der Zuckerkrankheit mit 80–85% angegeben, so daß nur ein kleiner Anteil dem primär insulinabhängigen Diabetes des Typ 1 zuzuordnen ist.

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   69.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   74.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Schliack V (1971) Die Verbreitung des Diabetes mellitus: Häufigkeit und Vorkommen in Europa und Amerika. In: Pfeiffer EF (Hrsg) Handbuch des Diabetes mellitus, Bd 2. Lehmanns, München, S 333–364

    Google Scholar 

  2. Bennett PH, LeCompte PM, Miller M, Rushforth NB (1976) Epidemiological studies of diabetes in the Pima Indians. Recent Prog Horm Res 32: 333–376

    PubMed  CAS  Google Scholar 

  3. Waldhäusl W (1983) Therapeutische Möglichkeiten zur Normalisierung der Glukosehomöostase bei Diabetikern. Hämostaseologie 3: 140–148

    Google Scholar 

  4. Miller Leone V, Goldstein J (1972) More efficient care of diabetic patients in a country-hospital setting. N Engl J Med 286: 1388–1391

    Article  PubMed  CAS  Google Scholar 

  5. Green A, Solander F (1984) Epidemiological studies of diabetes mellitus in Denmark. 6. Use of hospital services by insulin treated patients. Diabetologia 26: 195–198

    PubMed  CAS  Google Scholar 

  6. Deckert T, Poulsen JE, Larsen M (1979) The prognosis of insulin dependent diabetes mellitus and the importance of supervision. Acta Med Scand (Suppl) 624: 48–53

    CAS  Google Scholar 

  7. Panzram G, Zabel-Langhennig R (1981) Prognosis of diabetes mellitus in a geographically defined population. Diabetologia 20: 587–591

    Article  PubMed  CAS  Google Scholar 

  8. Bagdade JD et al. (1967) The significance of basal insulin levels in evaluation of the insulin response to glucose in diabetic and nondiabetic subjects. J Clin Invest 46: 1549–1557

    Article  PubMed  CAS  Google Scholar 

  9. Beischer W et al. (1984) The therapeutic and prognostic relevance of the fast beta-cell stimulation capacity. In: Melchionda N, Horwitz DC, Schade DS (eds) Recent advances in obesity and diabetes research. Raven Press, New York, p 1

    Google Scholar 

  10. Beischer W et al. (1976) C-Peptid als Parameter für die orale Diabetestherapie. Verh Dtsch Ges Inn Med 82: 791–794

    PubMed  CAS  Google Scholar 

  11. Beischer W et al. (1978) Humanes C-Peptid, Teil III: Sekretionsdynamik der Beta-Zellen erwachsener Diabetiker nach Glibenclamid-Glukose i.v. Klin Wochenschr 56: 111–120

    Article  PubMed  CAS  Google Scholar 

  12. Bodansky HJ et al. (1981) Plasma C-peptide in long-standing type 1 diabetics with and without microvascular disease. Diabete Metab 7: 265–269

    PubMed  CAS  Google Scholar 

  13. Fajans SS et al. (1978) Clinical and etiologic heterogeneity of idiopathic diabetes mellitus. Diabetes 27: 1112–1125

    Article  PubMed  CAS  Google Scholar 

  14. Holman RR, Turner RC (1979) Maintenance of basal plasma glucose and insulin concentrations in maturity-onset diabetes. Diabetes 28: 227–230

    Article  PubMed  CAS  Google Scholar 

  15. Madsbad S (1983) Prevalence of residual B-cell function and its metabolic consequences in type 1 (insulin-dependent) diabetes. Diabetologia 24: 141–147

    PubMed  CAS  Google Scholar 

  16. Madsbad S et al. (1981) Practical clinical value of the C-peptide response to glucagon stimulation in the choice of treatment in diabetes mellitus. Acta Med Scand 210: 153–156

    Article  PubMed  CAS  Google Scholar 

  17. Pfeifer MA et al. (1981) Insulin secretion in diabetes mellitus. Am J Med 70: 579–588

    Article  PubMed  CAS  Google Scholar 

  18. Pfeiffer EF et al. (1961) Über die Bestimmung von Insulin im Blute am epididymalen Fettanhang der Ratte mit Hilfe markierter Glukose. IV. Die Dynamik der Insulinsekretion des Stoffwechselgesunden und des Altersdiabetikers nach wiederholter Belastung mit Glukose, Sulfonylharnstoffen und menschlichem Wachstumshormon, ein Beitrag zur Pathogenese des menschlichen Altersdiabetes. Klin Wochenschr 39: 415–426

    Article  PubMed  CAS  Google Scholar 

  19. Pfeiffer EF, Raptis S (1972) Controlled extension of oral antidiabetic therapy on former insulin-dependent diabetics by means of the combined i.v. glibenclamide-glucose test. Diabetologia 8: 41–47

    Article  PubMed  CAS  Google Scholar 

  20. Pfeiffer EF et al. (1974) Einmalige intravenöse Glibenclamid-Glukose Belastung als Vorhersagetest. Dtsch Med Wochenschr 99: 1281–1294

    Article  PubMed  CAS  Google Scholar 

  21. Smith RBW et al. (1979) C-peptide response to glucagon in diabetics with and without complications. NZ Med J 89: 304–306

    CAS  Google Scholar 

  22. Tchobroutsky G (1978) Relation of diabetic control to development of microvascular complications. Diabetologia 15: 143–152

    Article  PubMed  CAS  Google Scholar 

  23. Adeniyi RO, Jones RH, Barnes DG, Gerlis LS, Sönksen PH (1983) Porcine and human insulin (Novo): a comparison of their metabolism and hypoglycaemic activity in normal man. Diabetes Care (Suppl 1 ) 6: 9–12

    Google Scholar 

  24. Arias P, Navascues I, Schäfauer G, Kerner W, Pfeiffer E (1983) Vergleichende Untersuchungen zur Wirksamkeit von semisynthetischem Humaninsulin und hochgereinigtem Schweineinsulin. Wien Med Wochenschr (Suppl) 76: 3

    Google Scholar 

  25. Bottermann P, Gyaram H, Wahl K, Ermler R, Lebender A (1981) Pharmacokinetics of biosynthetic human insulin and characteristics of its effect. Diabetes Care 4: 168–169

    Article  PubMed  CAS  Google Scholar 

  26. Dietze G, Wicklmayr M, Hepp KD, Bogner W, Mehnert H, Czempiel H, Henftling HG (1976) On gluconeogenesis of human liver. Accelerated hepatic glucose formation induced by increased precursor supply. Diabetologia 12: 555–561

    Article  PubMed  CAS  Google Scholar 

  27. Gutmann J, Rachel V, Brundl G (1969) Vergleichende Untersuchungen mit neuen rheographischen und plethysmographischen Durchblutungsmageräten. Elektromedizin 87: 38

    Google Scholar 

  28. Johansen K (1983) Human insulin — Medical progress? Metabolism 32: 528–532

    Article  PubMed  CAS  Google Scholar 

  29. Owens DR, Jones MK, Hayes TM, Heding LG, Alberti KGMM, Home PD, Burrin JM, Newcombe RG (1981) Human insulin: Study of safety and efficacy in man. Br J Med 282: 1264–1266

    Article  CAS  Google Scholar 

  30. Sonnenberg GE, Berger M (1983) Human insulin: Much ado about one amino acid— Diabetologia 25: 457–459

    CAS  Google Scholar 

  31. Wicklmayr M, Dietze G (1979) Untersuchungen zur Insulinsensitivität von Leber und Muskulatur des Menschen. Verh Dtsch Ges Inn Med 85: 993–997

    CAS  Google Scholar 

  32. Christiansen AH (1973) Radioimmunoelectrophoresis in the determination of insulin binding to IgG. Methodological studies. Horm Metab Res 5: 147–154

    Article  PubMed  Google Scholar 

  33. Federlin K, Velcovsky HG (1974) IgE-Antikörper bei Patienten mit Insulinallergie. Verh Dtsch Ges Inn Med 80: 1613–1617

    PubMed  CAS  Google Scholar 

  34. Fineberg SE, Galloway JA, Fineberg NS, Rathbun MJ, Hufferd S (1983) Immunogenicity of recombinant DNA human insulin. Diabetologia 25: 465–469

    Article  PubMed  CAS  Google Scholar 

  35. Gambhir K, Archer J, Carter L (1977) Insulin radioreceptor assay or human erythrocytes. Clin Chem 23: 1590–1595

    PubMed  CAS  Google Scholar 

  36. Laube H, Svedberg J, Velcovsky HG, Federlin K (1981) Biosynthetisches Humaninsulin — seine Wirkung auf Blutzucker, C-Peptid und Plasmacortisol beim Menschen. Verh Dtsch Ges Inn Med 87: 148–150

    Google Scholar 

  37. Schluter KJ (1983) Humaninsulin. Diabetes-Praxis 7: 1–7

    Google Scholar 

  38. Velcovsky HG, Federlin K (1982) Insulin specific IgG and IgE antibody response in type I diabetic subjects exclusively treated with human insulin. Diabetes Care 5: 126–132

    Article  PubMed  Google Scholar 

  39. Andersen O (1975) The immunogenic properties of highly purified insulin preparations. The clinical importance of insulin-binding antibodies. Acta Endocrinol (Kbh) 78: 723–735

    Google Scholar 

  40. Asplin CM et al. (1978) Change of insulin dosage, circulating free bound insulin and insulin antibodies on transferring diabetics from conventional to highly purified insulin. Diabetologia 14: 99–105

    Article  PubMed  CAS  Google Scholar 

  41. Christiansen AH (1973) Radioimmunoelectrophoresis in the determination of insulin binding to IgG. Methological studies. Horm Metab Res 5: 147–154

    Article  PubMed  Google Scholar 

  42. Deckert T, Lorup B (1976) Regulation of brittle diabetes by a pre-planned insulin infusion programme. Diabetologia 12: 537–579

    Article  Google Scholar 

  43. Deckert T, Lauritzen T (1982) Assessment of one-year insulin pump therapy. Diabetologia 23: 162–163

    Google Scholar 

  44. Federlin K et al. (1983) Immunologische Beobachtungen bei Primär-and Sekundärbehandlung von Diabetikern mit Humaninsulin. Miinch Med Wochenschr 125: 101–107

    Google Scholar 

  45. Irsigler K, Kritz H (1979) Long-term continous intravenous insulin therapy with a portable insulin dosage regulating apparatus. Diabetes 28: 196–203

    Article  PubMed  CAS  Google Scholar 

  46. Kurtz AB et al. (1978) Insulin-binding antibody: Reaction differences with bovine and porcine insulins. Diabetologia 15: 19–22

    Article  PubMed  CAS  Google Scholar 

  47. Koivisto VA et al. (1983) No evidence of amyloidosis in type I diabetics treated with continuous subcutaneous insulin infusion. Diabetes 32: 88–90

    Article  PubMed  CAS  Google Scholar 

  48. Levandoski LA et al. (1982) Localized skin reactions to insulin: insulin lipodystrophies and skin reactions to pumped subcutaneous insulin therapy. Diab Care 5: 6–10

    Article  Google Scholar 

  49. Lougheed WD et al. (1980) Insulin aggregation in artificial delivery systems. Diabetologia 19: 1–9

    Article  PubMed  CAS  Google Scholar 

  50. Mauer SM et al. (1983) Failure to finf amyloidosis in dogs treated with long-term intravenous insulin delivered by a totally implantable pump. Diabetologia 25: 448–450

    Article  PubMed  CAS  Google Scholar 

  51. Neuzner J et al. (1981) Short term treatment with a portable insulin pump influences diabetic autonomic neuropathy. Diabetologia 21: 308

    Google Scholar 

  52. Neuzner J et al. (1983) Long-term intravenous insulin infusion therapy in patient with insulin dependent diabetes mellitus and Addison’s disease. In: Irsigler K, Kritz H, Lovett R (eds) Diabetes treatment with implantable insulin infusion systems. Urban and Schwarzenberg, Munich Vienna Baltimore, pp 103–109

    Google Scholar 

  53. Pickup JC et al. (1978) Continous subcutaneous insulin infusion: an approach to achieving normoglycaemia. Br Med J 1: 204–207

    Article  PubMed  CAS  Google Scholar 

  54. Pietri A et al. (1980) Changes in nerve conduction velocity after six weeks of glucoregulation with portable insulin infusion pumps. Diabetes 29: 668–671

    Article  PubMed  CAS  Google Scholar 

  55. Sachse G et al. (1983) Treatment with a portable insulin infusion system influences autonomic diabetic neuropathy of the cardiovascular system. In: Irsigler K, Kritz H, Lovett R (eds) Diabetes treatment with implantable insulin infusion systems. Urban and Schwarzenberg, Munich Vienna Baltimore, pp 201–203

    Google Scholar 

  56. Schiffrin A, Belmonte M (1982) Comparison between continuous subcutaneous insulin infusion and multiple injections of insulin. Diabetes 31: 255–264

    Article  PubMed  CAS  Google Scholar 

  57. Schulz G et al. (1983) Implantable insulin infusion devices in the therapy of type I diabetes. In: Irsigler K, Kritz H, Lovett R (eds) Diabetes treatment with implantable insulin infusion systems. Urban and Schwarzenberg, Munich Vienna Baltimore, pp 110–118

    Google Scholar 

  58. Slama G et al. (1974) One to five days of continuous intravenous insulin infusion on seven diabetic patients. Diabetes 23: 732–739

    PubMed  CAS  Google Scholar 

  59. Teutsch SM et al. (1984) Mortality among diabetic patients using continuous subcutaneous insulin-infusion pumps. N Engl J Med 310: 361–368

    Article  PubMed  CAS  Google Scholar 

  60. Velcovsky HG, Federlin K (1982) Insulin-specific IgG and IgE antibody response in type I diabetic subjects exclusively treated with human insulin. Diab Care 5: 126–128

    Article  Google Scholar 

  61. Viberti G et al. (1981) Correction of exercise induced microalbuminuria in insulin dependent diabetics after 3 weeks of subcutaneous insulin infusion. Diabetes 30: 818–823

    Article  PubMed  CAS  Google Scholar 

  62. Williamson JR et al. (1982) Secondary amyloidosis in (beagle) dogs receiving intravenous insulin via mechanical pumps. Diabetes 31: 50A

    Google Scholar 

  63. Yue DK et al. (1975) Antigenicity of “Monocomponent” pork insulin in diabetic subjects. Diabetes 24: 625–632

    Article  PubMed  CAS  Google Scholar 

  64. Boulton AJM, Drury J, Clarke B, Ward JD (1982) Continuous subcutaneous insulin infusion in the management of painful diabetic neuropathy. Diab Care 5: 386–390

    Article  CAS  Google Scholar 

  65. Irsigler K, Kunz KM, Owens DR, Regal H (eds) New approaches to insulin therapy. Lancaster, MTP Press Ltd., pp 437–441

    Google Scholar 

  66. Pietri A, Ehle AL, Raskin P (1980) Changes in nerve conduction velocity after six weeks of glucoregulation with portable insulin infusion pumps. Diabetes 29: 668–671

    Article  PubMed  CAS  Google Scholar 

  67. Tolaymat A, Roque JL, Rosso LS Jr (1982) Improvement of diabetic peripheral neuropathy with the portable insulin infusion pump. South Med J 75: 185–189

    Article  PubMed  CAS  Google Scholar 

  68. White NH, Skor D, Santiago JV (1982) Long-term effect of intensive insulin therapy (ITT) on peripheral (PN) and autonomic (AN) neuropathy in insulindependent diabetics (IDDs) (Abstract). Diabetes (Suppl) 31: 66A

    Article  Google Scholar 

  69. Kästner E, Beyer J, Hassinger W, Schulz G, Cordes U (1980) Untersuchungen zum basalen und nahrungsabhängigen Insulinbedarf bei Diabetikern während kontinuierlicher intravenöser Insulininfusion mit tragbaren Minipumpen im Kurz-und Langzeitversuch. Aktuel Endokrinol Stoffwechselkr 1: 185

    Google Scholar 

  70. Blackshear PJ, Rohde TD, Prosl F, Buchwald H (1979) The implantable pump: a new concept of drug delivery. Med Prog Technol 6: 149

    PubMed  CAS  Google Scholar 

  71. Buchwald H, Rohde TD, Dorman FD, Skagoon JG, Wigness BD, Blackshear PJ, Varco RL (1980) A totally implantable drug infusion device: Laboratory and clinical experience using a model with single flow rate and new design for modulation insulin infusion. Diab Care 3: 351–358

    Article  CAS  Google Scholar 

  72. Schulz G, Beyer J, Hogan M, Cordes U, Kempf P (1983) Implantable insulin infusion devices in the therapy of type I diabetics. In: Irsigler K, Kritz H, Lovett R (eds) Diabetes treatment with implantable insulin infusion system. Urban und Schwarzenberg, München Wien Baltimore, p 110

    Google Scholar 

  73. Service FJ, Molnar GD, Rosewear JW, Ackermann E, Gatewood LC, Taylor WF (1970) Mean amplitude of glycemic excursions: a measure of diabetic instability. Diabetes 19: 644–655

    PubMed  CAS  Google Scholar 

  74. Schlichtkrull JO, Munk O, Jersild M (1965) The M-value an index of blood-sugar control in diabetics. Acta Med Scand 177: 95–102

    Article  PubMed  CAS  Google Scholar 

  75. Geisen K, Gerlach MH, Keil M (1981) Morphological in pancreatectomized dogs within an implanted insulin dosing device: Tissue reactions to the pump housing and to the vascular catheter. Horm Metab Res 15: 4–10

    Article  Google Scholar 

  76. Kashiwagi S, Morguet A, Schmitt V, Schonwald F, Kiesel U, Herberg L, Müntefering H (1981) Komplikationen der kontinuierlichen Insulininfusion bei Ratten. Acta Endokrinol (Kbh) 2: 95

    Google Scholar 

  77. Irsigler K, Kritz H (1982) Improvement of metabolic control with implanted insulin delivery devices in five diabetic patients-Long term feasibility. Diabetes 31: 654

    Google Scholar 

  78. Kritz H, Hagemüller G, Lovett R, Irsigler K (1983) Implanted constant basal rate insulin infusion devices for type 1 (insulin-dependent) diabetic patients. Diabetologia 25: 78–81

    Article  PubMed  CAS  Google Scholar 

  79. Pozza G, Spotti D, Micossi P, Christallo M, Melandri M, Piatri PM, Monti LD, Pontiroli AE (1983) Long-term continuous intraperitoneal insulin treatment in brittle diabetes. Br Med J 286: 255–256

    Article  CAS  Google Scholar 

  80. Krzentowski G, Pirnay F, Pallikarakis N, Luyckx AS, Lacroix M, Mosora F, Lefebvre PJ (1981) Glucose utilization during exercise in normal and diabetic subjects. Diabetes 30: 983–989

    Article  PubMed  CAS  Google Scholar 

  81. Berger M, Berclefeld P, Clippers HJ, Drost H, Kley HK, Muller WA, Wiegelmann W, Zimmermann-Teltschow, Gries A, Krüskemper HL, Zimmermann H (1977) Metabolic and hormonal effects of muscular exercise in juvenile type diabetics. Diabetologia 13: 355–365

    Article  PubMed  CAS  Google Scholar 

  82. Koivisto VA, Felig P (1977) Effects of exercise on insulin release from injection sites in diabetic man. Diabetes 26: 357–361

    Google Scholar 

  83. Martin MJ, Robbins DC, Bergenstal R, La Grange B, Rubenstein AH (1982) Absence of exercise induced hypoglycemia in type I diabetic patients during maintenance of normoglycemia by short term open loop insulin infusion. Diabetologia 23: 337–342

    Article  CAS  Google Scholar 

  84. Costill DL, Benett A, Branam G, Eddy D (1973) Glucose ingestion at rest and during prolonged exercise. J Appl Physiol 34: 764–769

    PubMed  CAS  Google Scholar 

  85. Caron D, Poussier P, Marliss EB, Zinman B (1982) The effect of postprandial exercise on meal related glucose intolerance in insulin dependent diabetic individuals. Diab Care 5: 364–369

    CAS  Google Scholar 

  86. WHO Expert Committee on Diabetes Mellitus (1980) Second report. WHO Technical Report Series 646, Geneva

    Google Scholar 

  87. Fajans SS, Conn JW (1959) The early recognition of diabetes mellitus. Ann NY Acad Sci 82: 208–218

    Article  PubMed  CAS  Google Scholar 

  88. WHO Expert Committee on Diabetes Mellitus (1956) First report. WHO Technical Report Series 310, Geneva

    Google Scholar 

  89. Jarrett RJ, Keen H, Fuller JH, McCartney M (1979) Worsening to diabetes in men with impaired glucose tolerance („borderline diabetes“). Diabetologia 16: 25–30

    Article  PubMed  CAS  Google Scholar 

  90. Keen H, Jarrett RJ, McCartney P (1982) The ten-year follow-up of the Bedford survey (1962–1972): Glucose tolerance and diabetes. Diabetologia 22: 73–78

    Article  PubMed  CAS  Google Scholar 

  91. Köbberling J, Appels A, Köbberling G, Creutzfeldt W (1969) Glucosebelastungstests bei 727 Verwandten 1. Grades von Altersdiabetikern. Dtsch Med Wochenschr 94: 416–421

    Article  PubMed  Google Scholar 

  92. Köbberling J, Kattermann R, Arhold A (1975) Follow up of „non diabetic“ relatives of diabetics by retesting oral glucose tolerance after 5 years. Diabetologia 11: 451–456

    Article  PubMed  Google Scholar 

  93. Köbberling J (1980) Zur Wertigkeit des oralen Glucosetoleranztests. Internist 21: 213–219

    PubMed  Google Scholar 

  94. Köbberling J (1982) Der prädiktive Wert diagnostischer Maßnahmen. Dtsch Med Wochenschr 107: 591–595

    Article  PubMed  Google Scholar 

  95. Haslbeck M (1981) Diagnostische Probleme bei Diabetes mellitus. Internist 22: 187–196

    PubMed  CAS  Google Scholar 

  96. Brekke IB, Aluments J, Sundler F (1983) The duct-ligated pancreas transplant and its effect on the islet cellular composition of the host pancreas. Cell Tissue Res 231: 205–213

    Article  PubMed  CAS  Google Scholar 

  97. Bretzel RG, Federlin K (1980) Islet transplantation in experimental diabetes mellitus of the rat. Biochemical and morphological findings. In: Bibergeil H, Zühlke H, Poser U (eds) Early diabetes. Pathogenesis, diagnosis, prevention. Central Institute for Diabetes „Gerhardt Katsch`, Karlsburg, p 290

    Google Scholar 

  98. Bretzel RG, Manns E, Schomber C, Federlin K (1978) Die Leber als Implantationsort far Langerhanssche Inseln beim experimentellen Diabetes mellitus. Verh Dtsch Ges Inn Med 84: 1213–1217

    PubMed  Google Scholar 

  99. Kramp RC, Burr IM (1981) Subcutaneous, isogeneic transplantation of duct-ligated pancreas in streptozotocin-diabetic mice. Relationships between carbohydrate tolerance and hormone content in transplant or host pancreas. Diabetes 30: 857–864

    Article  PubMed  CAS  Google Scholar 

  100. Trimble ER, Karakash C, Malaisse-Lagae F, Vassutine I, Orci L, Renold AE (1980) Effects of intraportale islet transplantation on the transplanted tissue and the recipient pancreas. I. Functional studies. Diabetes 26: 341–347

    Article  Google Scholar 

  101. Rüdiger, HW, Dreyer M, Kühnau J, Bartelheimer H (1983) Familial insulin-resistant diabetes secondary to an affinity defect of the insulin receptor. Hum Genet 64: 407–411

    Article  PubMed  Google Scholar 

  102. Pilch PF, Czech MP (1979) Interaction of cross-linking agents with the insulin effector system of isolated fat cells. J Biol Chem 254: 3375–3381

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

Copyright information

© 1984 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Waldhäusl, W. et al. (1984). Postersession III. In: 90. Kongreß. Verhandlungen der Deutschen Gesellschaft für Innere Medizin, vol 90. J.F. Bergmann-Verlag, Munich. https://doi.org/10.1007/978-3-642-85457-6_67

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-85457-6_67

  • Publisher Name: J.F. Bergmann-Verlag, Munich

  • Print ISBN: 978-3-8070-0342-9

  • Online ISBN: 978-3-642-85457-6

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics